Read + Share
Amedeo Smart
Independent Medical Education
Tiong IS, Dillon R, Ivey A, Teh TC, et al. Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia. Br J Haematol 2021;192:1026-1030.PMID: 32458446
Email
LinkedIn
Facebook
Twitter
Privacy Policy